GI Flashcards
(134 cards)
Crohn’s disease definition
A disorder of unknown aetiology characterised by granulomatous transmural inflammation of the GI tract. Usually seen in the terminal ilial, proximal colon and perianal location, but can affect ANY PART of the GI tract. Unlike ulcerative colitis, CD may have non-continuous skip lesions (normal bowel mucosa found between diseased areas). The transmural inflammation can also result in sinus tracts that burrow through and penetrate the serosa, giving rise to perforations and fistulae.
Macroscopic appearance: skp lesions, cobblestone appearance, thickened and narrowed.
Microscopic appearance: transmural, granulomas (non-ceseating), goblet cells present
Crohn’s disease aetiology
Unknown
Genetic - potential: inappropriate immune response against (possibly abnormal) colonic flora in genetically susceptible individuals
Environment: smoking, oral contraceptive pill, NSAIDs, stress
Crohn’s disease risk factors
Peak age of onset 14-40yrs Smoking Family history Mutation on NOD2 gene Equally present in men and women More common in white northern Europeans and N. America
Crohn’s disease pathophysiology
Acute transmural inflammation results in bowel obstruction due to mucosal oedema associate with spasm. Scarring, luminal narrowing and stricture formation occur due to the chronic inflammation.
Chronic inflammation damages the mucosa leading to deficient absorptive ability
Involvement at the terminal ileum interferes with bile acid absorption, leading to steatorrhea, fat-soluble vitamin deficiency and gallstone formation
Crohn’s disease key presentations
Can have mild symptoms in periods of remission followed by ‘flare ups’/exacerbatiions. Oral ulcers are common
Dependent on area affected:
Small bowel
- abdo pain
- weight loss
- right iliac fossa pain (less common)
Colon
- bloody diarrhoea
- pain on defecation
Systemic symptoms in attacks
- fever
- anorexia
- malaise
- fatigue
Signs
- bowel ulceration
- abdo tenderness
- abdo mass
- perianal disease
- extraintestinal signs: clubbing; oral apthous ulcers; more common than UC; skin, joint and eye problems
Crohn’s disease 1st line investigations
Ask for travel history, family history and medications to see any contributing causes.
Blood tests - raised WCC, raised platelets, raised CRP and ESR, normocytic anaemia of chronic disease, iron, folate, B12 deficiency, hypoalbuminaemia in severe, pANCA negative
Stool sample - exclude infection
Faecal calprotectin - raised in IBD
Gold standard
Colonoscopy with biopsy - can help determine severity, further radiological examinations can determine severity and transmural complications (eg fissure)
Crohn’s disease differential diagnosis
Ulcerative colitis, infective colitis, intestinal ichaemia, acute appendicitis, diverticulitis, IBS, malignancy such as tumour
Crohn’s disease management
No cure so treatment is intended to manage and improve symptoms.
1st treatment: corticosteroids such as prednisolone tablets or hydrocortisone injections (severe) - reduce inflammation. Side effects: weight gain, swelling of the face and osteopenia or osteoporosis. If the case is severe, immunosuppressants are considered. Surgery can also be considered if symptoms arent relieved.
Smoking cessation, treat iron/folate/B12 deficiency
Anti-TNF antibodies if no response to steroids: inflicimac, adalimumab
Azathioprine to maintain remission
Surgery last resort to remove most damaged area - short bowel syndrome = diarrhoea and malabsorption
Crohn’s disease monitoring
A surveillance colonoscopy is generally recommended eight to ten years after diagnosis of ulcerative colitis or Crohn’s disease involving the colon and every one to two years thereafter
Crohn’s disease complications
SAMPANOO
Systemic - amyloidosis. Thisis where the myloid protein builds up in organs + interferes with their function
Anemia
Malabsorption - due to the reduced absorptive function
Perforation
Anal issues - fistula, abscesses, fissure and skin tags
Neoplasia - colorectal cancer
Osteoporosis
Obstruction - due to acute swelling and chronic fibrosis
Crohn’s disease prognosis
Great prognosis - mortality rates low with management
Ulcerative colitis definition
A type of inflammatory bowel disease that usually involves the rectum and extends proximally to affect a variable length of the colon. It is recognised as a multifactorial poygenic disease.
Macroscopic appearance: continuous inflammation (no skip lesions), ulcrs, pseudo-polyps
Microscopic appearance: mucosal inflammation (no transmural inflammation_, no granulomata, depleted goblet cells, increased crypt abscesses
Ulcerative colitis epidemiology
More prevalent in Northern European population
Most patients are aged 20-40 at diagnosis with another peak at 60yrs
Uncommon in children
High incidence than Crohn’s
Smoking is protective
Ulcerative colitis aetiology
Unknown, possibly autoimmune: inappropriate immune response against (possibly abnormal) colonic flora in genetically susceptible individuals
Exacerbated by NSAIDs and stress
Ulcerative colitis pathophysiology
Relapses strongly associated with infectious enteritis
Ulcerative colitis key presentations
Remission and exacerbation
Ulcerative colitis signs and symptoms
Symptoms:
- pain in lower left quadrat
- diarrhoea with blood and mucus
- lower back pain from spondylitis (inflammation of spinal bones)
- systemic fever, anorexia, malaise, weight loss
Signs:
- fever (in acute UC)
- clubbing
- erythema nododsum (inflammation of subcutaneous fat)
- pyoderma gangrenosum - painful ulcers on skin
- malnutrition
- real ulcers
Ulcerative colitis 1st line investigations
Still studies: elevated feacal calprotein (useful for DDx but seen in both UC and Crohn’s), C.difficile toxins often present and associate with increase mortality (need at least 4 sample)
FBC: ESR and CRP may be elevated in flare-up, raised WCC and platelets, normocytic anaemia of chronic disease
pANCA: antibody found in 70% of UC patient (helps with DDx of CD)
Imagining:
- plain abdominal radiography
- ab x-ray
Ulcerative colitis gold standard investigations
Colonscopy with biopsy
- sigmoidoscopy for diagnosis
- full colonoscopy to define extent once controlled
Ulcerative colitis management
Aminosalicylate (1st lines): mesalazine or sulfasalzine
Add oral prednisolone if no response, IV hydrocortisone if severe
Azathioprine to maintain remission
Colectomy indicated in patients with severe UC and not responding to treatment
Ulcerative colitis complications
Toxic megacolon can occur with associated risk of perforation
Bpwel adenocarcinoma is a complication in 3-5% of patients
Joint problems such as arthritis
Hepatobiliary such as chronic pericholangitis and sclerosing cholangitis
Irritable bowel syndrome defintiion
A chronic condition characterised by abdominal pain associated with bowel dysfunction. There are no structural abnormalities to explain the pain
IBS-C: with constipation
IBS-D: with diarrhoea
IBS-M: mixed, with alternating constipation and diarrhoea
Irritable bowel syndrome epidemiology
Occurs in abotu 15% of the adult population - 1 in 5 western world
More common in female
Under 40s
Irritable bowel syndrome aetiology
Likelt multifactorial